GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » EV-to-EBITDA

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) EV-to-EBITDA : (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pharmedic Pharmaceutical Medicinal Joint Stock Company's enterprise value is ₫0.00 Mil. Pharmedic Pharmaceutical Medicinal Joint Stock Company does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA at this moment.

The historical rank and industry rank for Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA or its related term are showing as below:

HSTC:PMC's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.42
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Pharmedic Pharmaceutical Medicinal Joint Stock Company's stock price is ₫87000.00. Pharmedic Pharmaceutical Medicinal Joint Stock Company does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Pharmedic Pharmaceutical Medicinal Joint Stock Company's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Pharmedic Pharmaceutical Medicinal Joint Stock Company EV-to-EBITDA Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company EV-to-EBITDA Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
EV-to-EBITDA

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
EV-to-EBITDA

Competitive Comparison of Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA falls into.



Pharmedic Pharmaceutical Medicinal Joint Stock Company EV-to-EBITDA Calculation

Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=


Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=87000.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Pharmedic Pharmaceutical Medicinal Joint Stock Company EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012